Guanylyl cyclase C in colorectal cancer: susceptibility gene and potential therapeutic target

作者: Jieru E Lin , Peng Li , Giovanni M Pitari , Stephanie Schulz , Scott A Waldman

DOI: 10.2217/FON.09.14

关键词: ImmunologyGuanylinCancer researchColorectal cancerSignal transductionGuanylate cyclase 2CCancerUroguanylinContext (language use)Paracrine signallingMedicine

摘要: Colorectal cancer is one of the leading causes tumor-related morbidity and mortality worldwide. While mechanisms underlying this disease have been elucidated over past two decades, these molecular insights failed to translate into efficacious therapy. The oncogenomic view suggests that terminal transformation reflects sequential corruption signal transduction circuits regulating key homeostatic mechanisms, whose multiplicity underlies therapeutic resistance most tumors interventions targeting individual pathways. Conversely, paucity mechanistic proximal pathophysiological processes initiate amplify oncogenic preceding accumulation mutations impedes development effective prevention In context, guanylyl cyclase C (GCC), intestinal receptor for paracrine hormones guanylin uroguanylin, early loss characterizes colorectal transformation, has emerged as a component lineag...

参考文章(144)
B. Levin, P. Boyle, World Cancer Report 2008 ,(2009)
C. Sakanaka, P. Leong, L. Xu, S. D. Harrison, L. T. Williams, Casein kinase iepsilon in the wnt pathway: regulation of beta-catenin function. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 12548- 12552 ,(1999) , 10.1073/PNAS.96.22.12548
Osamu Tetsu, Frank McCormick, Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. ,vol. 398, pp. 422- 426 ,(1999) , 10.1038/18884
Charles H. Spruck, Kwang-Ai Won, Steven I. Reed, Deregulated cyclin E induces chromosome instability Nature. ,vol. 401, pp. 297- 300 ,(1999) , 10.1038/45836
Lei Xu, Ricky Tong, David M. Cochran, Rakesh K. Jain, Matrix metalloproteinase-2 contributes to cancer cell migration on collagen. Cancer Research. ,vol. 65, pp. 130- 136 ,(2005) , 10.1158/0008-5472.CAN-04-4313
P. Kleihues, B. W. Stewart, World Cancer Report ,(2003)
L FORTEJR, Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics Pharmacology & Therapeutics. ,vol. 104, pp. 137- 162 ,(2004) , 10.1016/J.PHARMTHERA.2004.08.007
Edward T Gawlinski, Robert A Gatenby, The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. Cancer Research. ,vol. 63, pp. 3847- 3854 ,(2003)
Sheelagh FRAME, Philip COHEN, GSK3 takes centre stage more than 20 years after its discovery. Biochemical Journal. ,vol. 359, pp. 1- 16 ,(2001) , 10.1042/0264-6021:3590001
G. M. Pitari, M. D. Di Guglielmo, J. Park, S. Schulz, S. A. Waldman, Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 7846- 7851 ,(2001) , 10.1073/PNAS.141124698